Patient and health practitioner views and experiences of a cancer trial before and during COVID-19: qualitative study.
Frances C SherrattPeter FisherAmy MathiesonMary G CherryAndrew R PettittBridget YoungPublished in: Trials (2022)
The findings point to ways trial communication can support patients to feel comfortable about continuing in a trial during uncertain times, including adopting a more in-depth, collaborative exploration of the risks and benefits of trial arms with patients and emphasising voluntariness. The results are relevant to trialists recruiting patients who are clinically extremely vulnerable or are at increased risk of poor COVID-19 outcomes despite being vaccinated.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- clinical trial
- study protocol
- healthcare
- peritoneal dialysis
- prognostic factors
- phase iii
- type diabetes
- randomized controlled trial
- sars cov
- coronavirus disease
- squamous cell carcinoma
- phase ii
- risk assessment
- adipose tissue
- skeletal muscle
- metabolic syndrome
- case report
- patient reported
- climate change
- young adults
- insulin resistance